The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2014 | ASH 2014: Ask the experts Q&A session 2
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr David Steensma (Dana-Farber Cancer Institute, Boston, MA), Dr Brent Wood (University of Washington, Seattle, WA), Prof Wendy Stock (University of Chicago Medical Center, Chicago, IL), Dr Christoph Röllig (Universitätsklinikum Dresden, Dresden, Germany), Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt, Germany), Dr Eytan Stein (Memorial Sloan-Kettering Cancer Center, New York, NY) and Prof Farhad Ravandi (The University of Texas MD Anderson Cancer Center, Houston, TX) answer questions from the press.
